Patents by Inventor Peter Willadsen

Peter Willadsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060088546
    Abstract: The present invention relates to the identification of polypeptides which are useful for raising an immune response against Ehrlichieae and Rickettsieae pathogens when administered into a subject. These polypeptides, and polynucleotides encoding therefor, can be used in various strategies for preventing or treating Ehrlichieae and Rickettsieae infections.
    Type: Application
    Filed: April 11, 2002
    Publication date: April 27, 2006
    Inventors: George Riding, Michelle Hope, Peter Willadsen
  • Publication number: 20050123557
    Abstract: Immunotherapy of protozoal diseases is provided by use of hypoxanthine guanine xanthine phosphoribosyl transferase protein, or peptide fragments thereof, as an immunogen in vaccines effective against protozoal diseases such as malaria and babesiosis. In particular, immunization with hypoxanthine guanine xanthine phosphoribosyl transferase or peptide fragments thereof, induces T cell immunity to blood stage malaria. In particular embodiments, the invention provides protein and DNA malaria vaccines and methods of prophylactic and therapeutic immunization that elicit T cell-mediated immune responses broadly applicable to protozoal diseases including malaria.
    Type: Application
    Filed: February 28, 2003
    Publication date: June 9, 2005
    Applicant: The Council of hte Queensland Institute of Medical Research
    Inventors: Morris Makobongo, George Riding, Peter Willadsen, Michael Good
  • Patent number: 6235283
    Abstract: This invention relates to an antigen isolated from the cattle tick Boophilus microplus and to the gene coding for that antigen and to the protein product of that gene. The antigen when used in part or in entirety as an immunogen administered to cattle as a vaccine results in the production by the cattle of an immune response which is capable of damaging ticks feeding on vaccinated cattle to such an extent that the survival of such ticks is decreased and/or the reproductive capacity of the ticks is decreased to such an extent that the antigen coded for by the gene can be used as an effective vaccine against said ticks.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: May 22, 2001
    Assignees: Biotechnology Australia Pty. Ltd., Commonwealth Scienticfic and Industrial Research Organization
    Inventors: Gary Stewart Cobon, Joanna Terry Moore, Law Anthony Yorke Johnston, Peter Willadsen, David Harold Kemp, Alagacone Sriskantha, George Alfred Riding, Keith Norman Rand
  • Patent number: 5587311
    Abstract: The invention relates to antigens derived from ticks and to their purification. It also relates to genes encoding such antigens and to their cloning and expression from recombinant DNA molecules. Further, the invention describes the use of purified antigens and recombinant expression products having similar biological activity to those purified antigens to provide vaccines to protect cattle against tick infestation.
    Type: Grant
    Filed: October 19, 1994
    Date of Patent: December 24, 1996
    Assignees: Biotechnology Australia Pty. Ltd., Commonwealth Scientific and Industrial Research Organization
    Inventors: Gary S. Cobon, Joanna T. Moore, Law A. Y. Johnston, Peter Willadsen, David H. Kemp, Alagacone Sriskantha, George A. Riding, Keith N. Rand